.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
Daiichi Sankyo
AstraZeneca
Johnson and Johnson
US Army
Queensland Health
US Department of Justice
Citi
Julphar

Generated: November 20, 2017

DrugPatentWatch Database Preview

Ifosfamide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ifosfamide and what is the scope of ifosfamide patent protection?

Ifosfamide
is the generic ingredient in four branded drugs marketed by West-ward Pharms Int, Teva Pharms Usa, Baxter Hlthcare, Fresenius Kabi Usa, and Mylan Labs Ltd, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for ifosfamide. Seven suppliers are listed for this compound.

Pharmacology for ifosfamide

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity

Medical Subject Heading (MeSH) Categories for ifosfamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
IFEX
ifosfamide
INJECTABLE;INJECTION019763-001Dec 30, 1988APRXYesNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
IFOSFAMIDE/MESNA KIT
ifosfamide; mesna
INJECTABLE;INTRAVENOUS075874-001Feb 26, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
IFOSFAMIDE
ifosfamide
INJECTABLE;INJECTION076657-001Apr 4, 2007APRXNoYes► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
IFOSFAMIDE/MESNA KIT
ifosfamide; mesna
INJECTABLE;INTRAVENOUS075874-002Feb 26, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
IFOSFAMIDE
ifosfamide
INJECTABLE;INJECTION076078-002May 28, 2002APRXNoYes► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
IFEX/MESNEX KIT
ifosfamide; mesna
INJECTABLE;INJECTION019763-003Oct 10, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
IFEX
ifosfamide
INJECTABLE;INJECTION019763-002Dec 30, 1988APRXYesNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
IFOSFAMIDE
ifosfamide
INJECTABLE;INJECTION076619-002Jun 29, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
IFOSFAMIDE
ifosfamide
INJECTABLE;INJECTION090181-001Sep 22, 2009APRXNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
IFEX/MESNEX KIT
ifosfamide; mesna
INJECTABLE;INJECTION019763-004Oct 10, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ifosfamide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare
IFEX
ifosfamide
INJECTABLE;INJECTION019763-001Dec 30, 1988► Subscribe► Subscribe
Baxter Hlthcare
IFEX
ifosfamide
INJECTABLE;INJECTION019763-002Dec 30, 1988► Subscribe► Subscribe
Baxter Hlthcare
IFEX
ifosfamide
INJECTABLE;INJECTION019763-002Dec 30, 1988► Subscribe► Subscribe
Baxter Hlthcare
IFEX
ifosfamide
INJECTABLE;INJECTION019763-001Dec 30, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Express Scripts
US Department of Justice
Harvard Business School
Medtronic
Novartis
Deloitte
Teva
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot